Antibiotice Statistics

Total Valuation

Antibiotice has a market cap or net worth of RON 1.20 billion. The enterprise value is 1.42 billion.

Market Cap	1.20B
Enterprise Value	1.42B

Important Dates

The next confirmed earnings date is Wednesday, May 27, 2026.

Earnings Date	May 27, 2026
Ex-Dividend Date	Oct 1, 2026

Share Statistics

Antibiotice has 671.34 million shares outstanding.

Current Share Class	671.34M
Shares Outstanding	671.34M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+0.12%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	0.69%
Float	227.94M

Valuation Ratios

The trailing PE ratio is 23.11.

PE Ratio	23.11
Forward PE	n/a
PS Ratio	1.81
PB Ratio	1.28
P/TBV Ratio	1.32
P/FCF Ratio	n/a
P/OCF Ratio	16.51
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.39, with an EV/FCF ratio of -20.29.

EV / Earnings	27.50
EV / Sales	2.16
EV / EBITDA	11.39
EV / EBIT	20.11
EV / FCF	-20.29

Financial Position

The company has a current ratio of 2.02, with a Debt / Equity ratio of 0.25.

Current Ratio	2.02
Quick Ratio	1.27
Debt / Equity	0.25
Debt / EBITDA	1.90
Debt / FCF	-3.38
Interest Coverage	15.85

Financial Efficiency

Return on equity (ROE) is 5.67% and return on invested capital (ROIC) is 5.24%.

Return on Equity (ROE)	5.67%
Return on Assets (ROA)	3.31%
Return on Invested Capital (ROIC)	5.24%
Return on Capital Employed (ROCE)	6.20%
Weighted Average Cost of Capital (WACC)	5.11%
Revenue Per Employee	487,115
Profits Per Employee	38,206
Employee Count	1,356
Asset Turnover	0.49
Inventory Turnover	1.46

Taxes

In the past 12 months, Antibiotice has paid 8.38 million in taxes.

Income Tax	8.38M
Effective Tax Rate	13.93%

Stock Price Statistics

The stock price has decreased by -12.88% in the last 52 weeks. The beta is 0.28, so Antibiotice's price volatility has been lower than the market average.

Beta (5Y)	0.28
52-Week Price Change	-12.88%
50-Day Moving Average	1.95
200-Day Moving Average	2.34
Relative Strength Index (RSI)	34.12
Average Volume (20 Days)	304,485

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Antibiotice had revenue of RON 660.04 million and earned 51.77 million in profits. Earnings per share was 0.08.

Revenue	660.04M
Gross Profit	400.50M
Operating Income	70.77M
Pretax Income	60.15M
Net Income	51.77M
EBITDA	124.98M
EBIT	70.77M
Earnings Per Share (EPS)	0.08

Full Income Statement

Balance Sheet

The company has 9.94 million in cash and 237.05 million in debt, giving a net cash position of -227.11 million or -0.34 per share.

Cash & Cash Equivalents	9.94M
Total Debt	237.05M
Net Cash	-227.11M
Net Cash Per Share	-0.34
Equity (Book Value)	932.07M
Book Value Per Share	1.39
Working Capital	255.33M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 72.44 million and capital expenditures -142.61 million, giving a free cash flow of -70.17 million.

Operating Cash Flow	72.44M
Capital Expenditures	-142.61M
Depreciation & Amortization	54.20M
Net Borrowing	92.51M
Free Cash Flow	-70.17M
FCF Per Share	-0.10

Full Cash Flow Statement

Margins

Gross margin is 60.68%, with operating and profit margins of 10.72% and 7.84%.

Gross Margin	60.68%
Operating Margin	10.72%
Pretax Margin	9.11%
Profit Margin	7.84%
EBITDA Margin	18.93%
EBIT Margin	10.72%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.04, which amounts to a dividend yield of 1.97%.

Dividend Per Share	0.04
Dividend Yield	1.97%
Dividend Growth (YoY)	-3.31%
Years of Dividend Growth	n/a
Payout Ratio	30.81%
Buyback Yield	n/a
Shareholder Yield	1.96%
Earnings Yield	4.33%
FCF Yield	-5.87%

Dividend Details

Stock Splits

The last stock split was on May 13, 2013. It was a forward split with a ratio of 1.1819213313.

Last Split Date	May 13, 2013
Split Type	Forward
Split Ratio	1.1819213313

Scores

Antibiotice has an Altman Z-Score of 3.61 and a Piotroski F-Score of 5.

Altman Z-Score	3.61
Piotroski F-Score	5